Direct differentiation of dopaminergic (DA) neurons from human pluripotent stem cells (hPSCs) in the absence of gene manipulation is the most desired alternative to clinical treatment of Parkinson disease. Protein transduction-based methods could be efficient, safe approaches to enhance direct differentiation of human embryonic stem cells (hESCs) to DA neurons. In the present study, we compared the differentiation efficiency of DA neurons from hESCs with and without the application of LIM homeobox transcription factor 1 alpha (LMX1A), a master regulatory protein in the development of the midbrain neurons and SHH proteins. The results obtained revealed that the treatment of hESCs with recombinant LMX1A (rLMX1A) protein along with dual SMAD inhibition led to higher expression of LMX1B, LMX1A, FOXA2, PITX3, EN1, and WNT1 effector endogenous genes and two-fold expression of PITX3. Moreover, the highest expression level of PITX3 and TH was observed when rLMX1A was added to the induction medium supplemented with SHH. To our best knowledge, this is the first report demonstrating the application of TAT-LMX1A recombinant protein to enhance hESC differentiation to DA as shown by the expression of DA specific makers. These findings pave the way for enhancing the differentiation of hESCs to DA neurons safely and efficiently without genetic modification.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Human embryonic stem cell
Trans-activator of transcription
Cho, M. S., Lee, Y. E., Kim, J. Y., Chung, S., Cho, Y. H., Kim, D. S., et al. (2008). Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 3392–3397.
Fasano, C. A., Chambers, S. M., Lee, G., Tomishima, M. J., & Studer, L. (2010). Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell, 6, 336–347.
Lee, H. S., Bae, E. J., Yi, S. H., Shim, J. W., Jo, A. Y., Kang, J. S., et al. (2010). Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells, 28, 501–512.
Ganat, Y. M., Calder, E. L., Kriks, S., Nelander, J., Tu, E. Y., Jia, F., et al. (2012). Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. Clinical Investigation, 122, 2928–2939.
Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature, 480, 547–551.
Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., & Lundblad, M. (2012). Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Reports, 1, 703–714.
Hegarty, S. V., Sullivan, A. M., & O’Keeffe, G. W. (2013). Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Developmental Biology, 379, 123–138.
Studer, L. (2012). Derivation of dopaminergic neurons from pluripotent stem cells. Progress in Brain Research, 200, 243–263.
Gump, J. M., & Dowdy, S. F. (2007). Tat transduction: the molecular mechanism and therapeutic prospects. Trends in Molecular Medicine, 13, 443–448.
Dietz, G. P., & Bahr, M. (2007). Synthesis of cell-penetrating peptides and their application in neurobiology. Methods in Molecular Biology, 399, 181–198.
Dietz, G. P., & Bahr, M. (2004). Delivery of bioactive molecules into the cell: the Trojan horse approach. Molecular and Cellular Neurosciences, 27, 85–131.
Andersson, E., Tryggvason, U., Deng, Q., Friling, S., Alekseenko, Z., Robert, B., et al. (2006). Identification of intrinsic determinants of midbrain dopamine neurons. Cell, 124, 393–405.
Ono, Y., Nakatani, T., Sakamoto, Y., Mizuhara, E., Minaki, Y., Kumai, M., et al. (2007). Differences in neurogenic potential in floor plate cells along an anteroposterior location: Midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development, 134, 3213–3225.
Chung, S., Kim, C. H., & Kim, K. S. (2012). Lmx1a regulates dopamine transporter gene expression during ES cell differentiation and mouse embryonic development. Journal of Neurochemistry, 122, 244–250.
Ang, S. L. (2006). Transcriptional control of midbrain dopaminergic neuron development. Development, 133, 3499–3506.
Friling, S., Andersson, E., Thompson, L. H., Jonsson, M. E., Hebsgaard, J. B., Nanou, E., et al. (2009). Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 106, 7613–7618.
Sanchez-Danes, A., Consiglio, A., Richaud, Y., Rodriguez-Piza, I., Dehay, B., Edel, M., et al. (2012). Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of Lmx1a in human embryonic stem cells and induced pluripotent stem cells. Human Gene Therapy, 23, 56–69.
Pfisterer, U., Kirkeby, A., Torper, O., Wood, J., Nelander, J., Dufour, A., et al. (2011). Direct conversion of human fibroblasts to dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America, 108, 10343–10348.
Caiazzo, M., Dell’Anno, M. T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo, D., et al. (2011). Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature, 476, 224–227.
Wadia, J. S., & Dowdy, S. F. (2002). Protein transduction technology. Current Opinion in Biotechnology, 13, 52–56.
Kwon, Y. D., Oh, S. K., Kim, H. S., Ku, S. Y., Kim, S. H., Choi, Y. M., et al. (2005). Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. Molecular Therapy: The Journal of The American Society of Gene Therapy, 12, 28–32.
Noda, T., Kawamura, R., Funabashi, H., Mie, M., & Kobatake, E. (2006). Transduction of Neurod2 protein induced neural cell differentiation. Journal of Biotechnology, 126, 230–236.
Stock, K., Nolden, L., Edenhofer, F., Quandel, T., & Brustle, O. (2010). Transcription factor-based modulation of neural stem cell differentiation using direct protein transduction. Cellular and Molecular Life Sciences, 67, 2439–2449.
Fonoudi, H., Yeganeh, M., Fattahi, F., Ghazizadeh, Z., Rassouli, H., Alikhani, M., et al. (2013). ISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cells. PloS One, 8, e55577.
Kim, D., Kim, C. H., Moon, J. I., Chung, Y. G., Chang, M. Y., Han, B. S., et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4, 472–476.
Bosnali, M., & Edenhofer, F. (2008). Generation of transducible versions of transcription factors Oct4 and Sox2. Biological Chemistry, 389, 851–861.
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381–384.
Cho, H. J., Lee, C. S., Kwon, Y. W., Paek, J. S., Lee, S. H., Hur, J., et al. (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood, 116, 386–395.
Zhang, H., Ma, Y., Gu, J., Liao, B., Li, J., Wong, J., et al. (2012). Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors. Biomaterials, 33, 5047–5055.
Nemes, C., Varga, E., Polgar, Z., Klincumhom, N., Pirity, M. K., & Dinnyes, A. (2013). Generation of mouse induced pluripotent stem cells by protein transduction. Tissue Engineering Part C: Methods., 20, 383–392.
Chung, S., Leung, A., Han, B. S., Chang, M. Y., Moon, J. I., Kim, C. H., et al. (2009). Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-Foxa2 pathway. Cell Stem Cell, 5, 646–658.
Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., Lundblad, M., et al. (2012). Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Reports, 1, 703–714.
Gale, E., & Li, M. (2008). Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells. Molecular Brain, 1, 8.
Doeppner, T. R., Dietz, G. P., El Aanbouri, M., Gerber, J., Witte, O. W., Bahr, M., et al. (2009). TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia. Neurobiology of Disease, 34, 87–94.
Baharvand, H., Ashtiani, S. K., Valojerdi, M. R., Shahverdi, A., Taee, A., & Sabour, D. (2004). Establishment and in vitro differentiation of a new embryonic stem cell line from human blastocyst. Differentiation, 72, 224–229.
Rassouli, H., Tabe Bordbar, M. S., Rezaei Larijani, M., Pakzad, M., Baharvand, H., & Salekdeh, G. H. (2013). Cloning, expression and functional characterization of in-house prepared human basic fibroblast growth factor. Cell Journal, 14, 282–291.
This study was funded through the grants provided by Royan Institute (#90000499). We are grateful to the members of the Department of Stem Cells and Developmental Biology, Royan Institure, for their critical comments.
Conflict of interest
The authors declare they have no competing financial interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Fathi, A., Rasouli, H., Yeganeh, M. et al. Efficient Differentiation of Human Embryonic Stem Cells Toward Dopaminergic Neurons Using Recombinant LMX1A Factor. Mol Biotechnol 57, 184–194 (2015). https://doi.org/10.1007/s12033-014-9814-5
- Dopaminergic neuron
- Protein transduction